This RRR account was set up solely for Pharmacy’s purpose of capturing charges that are not being reimbursed by the National Surgical Adjuvant Breast and Bowel Project (NSABP). The Charges to the account will be for dispensing fees and administrative sup May 5, 2022 By Jesse Bufkin
SynCardia temporary Total Artificial Heart (TAH-t) Postmarket Surveillance Study May 5, 2022 By Jesse Bufkin
A Randomized, Double-Blind, Placebo Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subejcts Undergoing Aromatase Inhibitor Therapy for Non-Metastatic Breast Cancer May 5, 2022 By Jesse Bufkin
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Managementof Myeloma in Patients up to 6 May 5, 2022 By Jesse Bufkin
A Pilot Study of Vorinostat to Restore Sensitivity to Aromatase Inhibitor Therapy Part B May 5, 2022 By Jesse Bufkin
In Vivo Assessment of Ductal Carcinoma in Situ Grade with Multiparametric MRI May 5, 2022 By Jesse Bufkin
A Randomized, Open-Label, Phase III Study of Taxane Based Chemotherapy with Lapatinib or Trastuzumab as First-Line Therapy for Women with HER2/neu Positive Metastratic Breast Cancer May 5, 2022 By Jesse Bufkin
This account is solely for the purpose of capturing pharmacy charges that are not being reimbursed by the Gynecology Oncology Group (GOG). The charges to the account will be for dispensing fees and administrative support (i.e. drug procurement and storage May 5, 2022 By Jesse Bufkin
A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Crohn’s Disease (OPERA II) May 5, 2022 By Jesse Bufkin
